The projects will strengthen the bridge between the University of Vienna and the Medical University Vienna and will promote the transfer of basic research to patient-oriented applications.
Since this funding instrument has worked so well in the past, four new projects were selected based on a call for proposals with a competitive selection process. The four successful projects will start in 2017 and will be funded for three years. The projects will thus contribute to strengthening translational research at both Universities and in the whole Vienna region.
"Novel scaffolds for GABAA receptor modulators"
Steffen Hering (Department of Pharmacology and Toxicology) and Thierry Langer (Department of Pharmaceutical Chemistry), University of Vienna and Stefan Böhm, MedUni Vienna, Center for Physiology and Pharmacolog
"Shared and modular resources in the human brain as a basis for new therapeutic interventions"
Roland Beisteiner, MedUni Vienna, Department of Neurology and Tecumseh Fitch, University of Vienna, Department of Cognitive Biology
"The premature gut microbiome and the influence on neonatal immunity, brain development and white matter injury"
David Berry, University of Vienna, Department of Microbiology and Ecosystem Science and Angelika Berger, MedUni Vienna, Department of Pediatrics and Adolescent Medicine
"Translational Cancer Therapy Research"
Walter Berger, MedUni Vienna, Department of Medicine I and Bernhard K. Keppler, University of Vienna, Institute of Inorganic Chemistry